These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35896779)

  • 1. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing.
    Kelley CJ; Niznik JD; Ferreri SP; Schlusser C; Armistead LT; Hughes TD; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2023 Dec; 40(12):1113-1122. PubMed ID: 37792262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines.
    Hawkins EJ; Lott AM; Danner AN; Malte CA; Hagedorn HJ; Berger D; Donovan LM; Sayre GG; Mariano AJ; Saxon AJ
    Pain Med; 2021 Jul; 22(7):1559-1569. PubMed ID: 33661287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.
    Ng BJ; Le Couteur DG; Hilmer SN
    Drugs Aging; 2018 Jun; 35(6):493-521. PubMed ID: 29705831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.
    Hürlimann O; Alers D; Hauri N; Leist P; Schneider C; Bolt L; Rodondi N; Aubert CE
    BMC Geriatr; 2024 May; 24(1):396. PubMed ID: 38704540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.
    Anderson TS; Wang BX; Lindenberg JH; Herzig SJ; Berens DM; Schonberg MA
    JAMA Netw Open; 2024 Mar; 7(3):e241342. PubMed ID: 38446478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the barriers and enablers of benzodiazepines deprescribing in prisons: A qualitative study among health and social care professionals.
    Fay C; Bonsergent M; Saillard J; Huon JF; Prot-Labarthe S
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):28-38. PubMed ID: 37276582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics.
    Gray SL; Fornaro R; Turner J; Boudreau DM; Wellman R; Tannenbaum C; Marcum ZA; Balderson B; Cook A; Jacobsen AL; Phelan EA
    J Am Geriatr Soc; 2023 May; 71(5):1580-1586. PubMed ID: 36546768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study.
    Hahn EE; Munoz-Plaza CE; Lee EA; Luong TQ; Mittman BS; Kanter MH; Singh H; Danforth KN
    J Gen Intern Med; 2021 Oct; 36(10):3015-3022. PubMed ID: 33469744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia.
    Niznik J; Colón-Emeric C; Thorpe CT; Kelley CJ; Gilliam M; Lund JL; Hanson LC
    J Gen Intern Med; 2023 Nov; 38(15):3372-3380. PubMed ID: 37369891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.
    de Kleijn L; Jansen-Groot Koerkamp EAW; van der Kooij I; Veen M; Rijkels-Otters HJBM; Koes BW; Chiarotto A
    Eur J Pain; 2024 Aug; 28(7):1101-1115. PubMed ID: 38287911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.
    McCann C; McCauley CO; Harkin D
    J Adv Nurs; 2024 Jun; 80(6):2500-2511. PubMed ID: 38082475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey.
    van Poelgeest EP; Seppala LJ; Lee JM; Bahat G; Ilhan B; Lavan AH; Mair A; van Marum RJ; Onder G; Ryg J; Fernandes MA; Garfinkel D; Guðmundsson A; Hartikainen S; Kotsani M; Montero-Errasquín B; Neumann-Podczaska A; Pazan F; Petrovic M; Soulis G; Vankova H; Wehling M; Wieczorowska-Tobis K; van der Velde N;
    Eur Geriatr Med; 2022 Dec; 13(6):1455-1466. PubMed ID: 36319837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
    Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
    J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.